Landscape of Noncoding RNA in the Hypoxic Tumor Microenvironment
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Hypoxic solid tumors involve noncoding RNAs (ncRNAs), including long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs). These molecules are key in cancer progression and offer potential as biomarkers and therapeutic targets.
Area Of Science
- Molecular Oncology
- Cancer Biology
- RNA Therapeutics
Background
- Solid tumors frequently exhibit a hypoxic microenvironment, influencing cancer progression.
- Noncoding RNAs (ncRNAs), including long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs), play critical roles in cancer transcriptomes.
- Emerging evidence highlights the significance of ncRNAs within hypoxic tumor regions.
Purpose Of The Study
- To comprehensively review recent studies on lncRNAs and circRNAs in the hypoxic tumor microenvironment.
- To emphasize the clinical significance of these ncRNAs in cancer diagnosis and treatment.
- To explore their potential as biomarkers and therapeutic targets for effective cancer therapies.
Main Methods
- Literature review of recent studies focusing on lncRNAs and circRNAs in hypoxic tumors.
- Analysis of biological functions and regulatory roles of lncRNAs and circRNAs.
- Evaluation of clinical applications in RNA-based treatments and liquid biopsies.
Main Results
- lncRNAs and circRNAs exhibit significant regulatory functions within the hypoxic tumor microenvironment.
- These ncRNAs demonstrate potential as promising biomarkers for cancer diagnosis.
- They also represent viable targets for novel RNA-based cancer therapies and noninvasive diagnostics.
Conclusions
- lncRNAs and circRNAs are crucial players in hypoxic tumor development and progression.
- Their distinct properties make them valuable for clinical applications in cancer management.
- Further research into these ncRNAs could lead to the development of effective targeted therapies.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...